Technology
Health
Medical

Eyenovia

314

$2.89
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) As of 6:21 PM EDT after-hours

Why Robinhood?

You can buy or sell Eyenovia and other stocks, options, ETFs, and crypto commission-free!

About EYEN

Eyenovia, Inc. Common Stock, also called Eyenovia, is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. Read More The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY.

CEO
Sean Ianchulev
Employees
27
Headquarters
New York, New York
Founded
2014
Market Cap
57.15M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
51.82K
High Today
$2.90
Low Today
$2.78
Open Price
$2.90
Volume
38.90K
52 Week High
$5.50
52 Week Low
$1.11

Collections

Technology
Health
Medical
Biopharmaceutical
Research And Development
Therapy
Pharmaceutical
2018 IPO

EYEN Earnings

-$0.60
-$0.40
-$0.20
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Aug 10, After Hours

You May Also Like

CNDT
CQP
YGRN
D
CMU
IBTH
QEP
ABR-C
DTSS
BELFA
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy EYEN

Market Price$2.89
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Eyenovia stock and options commission-free.
LearnBlogCareersHelpLog InSign Up